Recent Finacing
Recent Raise
Accent Therapeutics develops small-molecule oncology drugs targeting RNA-modifying proteins using a discovery platform that maps RMP dependencies to advance programs (METTL3, ADAR1, DHX9, KIF18A) for specific cancer indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
